🔎 Trials Near Me

መነሻ › ኖን-ሆጅኪን ሊምፎማ › Texas › Houston

በHouston፣ TX ለኖን-ሆጅኪን ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለኖን-ሆጅኪን ሊምፎማ የሚደረጉ 31 ጥናቶች በHouston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Md Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT05006716

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
እድሜ ከ12 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06176690

Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
እስከ እድሜ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT01853631

CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
እድሜ ከ12 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT02917083

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Texas Children's Hospital, Houston
እድሜ ከ0 እስከ 38 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06131801

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • The University of Texas MD Anderson Cancer Center, Houston
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT02693535

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Baylor College of Medicine, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07226843

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Md Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT07195916

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, Houston
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT06137144

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Research Site, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT06526793

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The University of Texas MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT07082803

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Clinical Trial Site, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT06393738

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04851119

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Texas MD Anderson Cancer Center, Houston
እድሜ ከ13 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT07188558

Personalized NK Cell Therapy in CBT

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • M D Anderson Cancer Center, Houston
እድሜ ከ15 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁላይ 2026 · NCT02727803

DALY II USA/ MB-CART2019.1 for DLBCL

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • The University of Texas MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ጁላይ 2026 · NCT04792489

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • M.D. Anderson Cancer Center, Houston
  • Texas Children's Hospital - Baylor Medical Center, Houston
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT01351545

EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Harris Health System - Ben Taub General Hospital/Smith Clinic, Houston
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
  • እና 1 ተጨማሪ
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ25 ጁን 2026 · NCT04664179

Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • M D Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT05529069

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • MD Anderson Cancer Center, Houston
እድሜ 13 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT04771572

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ኤፕሪ 2026 · NCT03328078

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Harris Health System (includes ben Taub General Hospital and Smith), Houston
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ2 ማርች 2026 · NCT01555892

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

ተሳታዮችን በመፈለግ ላይደረጃ 4
  • University of Texas MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ማርች 2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 4
  • University of Texas MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ማርች 2026 · NCT06876662

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Oncology Consultants, Houston
  • University of Texas MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ዲሴም 2025 · NCT05602363

A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • MD Anderson, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኖቬም 2025 · NCT04496349

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, Houston
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Texas MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ጁን 2025 · NCT06119685

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ዲሴም 2024 · NCT05967416

በሌሎች ከተሞች ለኖን-ሆጅኪን ሊምፎማ የሚደረጉ ጥናቶች

በHouston ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።